These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4752584)

  • 21. Use of bumetanide in the treatment of ascites due to liver disease.
    Moult PJ; Lunzer MR; Trash DB; Sherlock S
    Gut; 1974 Dec; 15(12):988-92. PubMed ID: 4448415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender effect on diuretic response to hydrochlorothiazide and furosemide.
    Franson KL; Kuk JM; Lam NP; Lau AH
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):101-5. PubMed ID: 8705087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
    Lowenthal DT; Shear L
    Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation in man of bumetanide, a new diuretic agent.
    Henning R; Lundvall O
    Eur J Clin Pharmacol; 1973 Dec; 6(4):224-7. PubMed ID: 4777256
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical comparative trial of piretanide and furosemide in patients with advanced renal insufficiency. Drug levels and diuretic potency of single oral doses].
    Heuer LJ; Machnik H; Studt J; Fink R
    Arzneimittelforschung; 1983; 33(9):1318-21. PubMed ID: 6685516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bumetanide in the treatment of hepatic ascites. A short and long-term study.
    Ring-Larsen H
    Acta Med Scand; 1974 May; 195(5):411-4. PubMed ID: 4830058
    [No Abstract]   [Full Text] [Related]  

  • 28. [Supra-additive natriuretic effect of theophyllamine in patients with chronic congestive heart failure during long-term therapy with bumethanide].
    Sigurd B
    Ugeskr Laeger; 1973 Oct; 135(41):2218-22. PubMed ID: 4775646
    [No Abstract]   [Full Text] [Related]  

  • 29. Diuretic therapy in experimental right heart failure of the rhesus monkey.
    Hastings SG; Johnston DJ; Blouin LT
    J Pharmacol Exp Ther; 1972 Mar; 180(3):748-53. PubMed ID: 4622309
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dose-response relationship of bumetanide in healthy subjects].
    Baethke VR; Kampf D
    Arzneimittelforschung; 1975 Apr; 25(4):666-8. PubMed ID: 1174085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone.
    Radó JP; Molnár Z; Hartai A; Gercsák G
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):532-7. PubMed ID: 7174156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [On the diuretic therapy of acute poisoning with somnifacients].
    Krüger GA
    Anaesthesist; 1967 Feb; 16(2):40-4. PubMed ID: 5586277
    [No Abstract]   [Full Text] [Related]  

  • 33. A study of two diuretic/potassium combinations in heart failure.
    Hussain M; Walton K; Davidson C; Morgan DB
    Postgrad Med J; 1985 Jan; 61(711):29-33. PubMed ID: 3991397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological properties of 3-n-butylamino-4-phenoxy-5-sulfamylbenzoic acid (Bumetanide), a new potent diuretic.
    Ostergaard EH; Magnussen MP; Nielsen CK; Eilertsen E; Frey HH
    Arzneimittelforschung; 1972 Jan; 22(1):66-72. PubMed ID: 5067001
    [No Abstract]   [Full Text] [Related]  

  • 36. The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
    Sigurd B; Olesen KH; Wennevold A
    Am Heart J; 1975 Feb; 89(2):163-70. PubMed ID: 1090132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
    Lennhoff M; Duhalt R; Peña JC
    Rev Invest Clin; 1968; 20(2):165-80. PubMed ID: 5721631
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of furosemide regimens in neonates treated with extracorporeal membrane oxygenation.
    van der Vorst MM; Wildschut E; Houmes RJ; Gischler SJ; Kist-van Holthe JE; Burggraaf J; van der Heijden AJ; Tibboel D
    Crit Care; 2006; 10(6):R168. PubMed ID: 17140428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bumetanide--acute and long-term studies of a new high potency diuretic.
    Murdoch WR; Auld WH
    Postgrad Med J; 1975; 51 Suppl 6():64-69. PubMed ID: 1105535
    [No Abstract]   [Full Text] [Related]  

  • 40. An open comparative study of two diuretic combinations, frusemide/amiloride ('Frumil') and bumetanide/potassium chloride ('Burinex' K), in the treatment of congestive cardiac failure in hospital out-patients.
    Ramsay F; Crawford RJ; Allman S; Bailey R; Martin A
    Curr Med Res Opin; 1988; 10(10):682-9. PubMed ID: 3371084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.